Search Results - "Tajima, Takeshi"

Reverse Genetics System for a Human Group A Rotavirus by Kawagishi, Takahiro, Nurdin, Jeffery A, Onishi, Misa, Nouda, Ryotaro, Kanai, Yuta, Tajima, Takeshi, Ushijima, Hiroshi, Kobayashi, Takeshi

“…Group A rotavirus (RV) is a major cause of acute gastroenteritis in infants and young children worldwide. Recently, we established an entirely plasmid-based…”
Get full text

Etiology of Acute Otitis Media and Characterization of Pneumococcal Isolates after Introduction of 13-Valent Pneumococcal Conjugate Vaccine in Japanese Children by Ubukata, Kimiko, Morozumi, Miyuki, Sakuma, Megumi, Takata, Misako, Mokuno, Eriko, Tajima, Takeshi, Iwata, Satoshi

“…BACKGROUND:Acute otitis media (AOM) is a leading cause of childhood morbidity and antibiotic prescriptions. We examined etiologic changes in AOM after…”
Get full text

Rapid Effectiveness of Minocycline or Doxycycline Against Macrolide-Resistant Mycoplasma pneumoniae Infection in a 2011 Outbreak Among Japanese Children by Okada, Takafumi, Morozumi, Miyuki, Tajima, Takeshi, Hasegawa, Maki, Sakata, Hiroshi, Ohnari, Shigeru, Chiba, Naoko, Iwata, Satoshi, Ubukata, Kimiko

“…Background. Mycoplasma pneumoniae is a major pathogen causing community-acquired pneumonia in children and young adults. Outbreaks typically occur at intervals…”
Get full text

Capmatinib in Japanese patients with MET exon 14 skipping–mutated or MET‐amplified advanced NSCLC: GEOMETRY mono‐1 study by Seto, Takashi, Ohashi, Kadoaki, Sugawara, Shunichi, Nishio, Makoto, Takeda, Masayuki, Aoe, Keisuke, Moizumi, Sanae, Nomura, Satoshi, Tajima, Takeshi, Hida, Toyoaki

“…MET mutations leading to exon 14 skipping (METΔex14) are strong molecular drivers for non–small‐cell lung cancer (NSCLC). Capmatinib is a highly potent,…”
Get full text

Phase I study of single‐agent ribociclib in Japanese patients with advanced solid tumors by Doi, Toshihiko, Hewes, Becker, Kakizume, Tomoyuki, Tajima, Takeshi, Ishikawa, Norifumi, Yamada, Yasuhide

“…The cyclin D‐CDK4/6‐INK4‐Rb pathway is frequently dysregulated in cancers. Ribociclib, an orally available, selective CDK4/6 inhibitor, showed preliminary…”
Get full text

Sequence Type Changes Associated with Decreasing Macrolide-Resistant Mycoplasma pneumoniae, Japan by Morozumi, Miyuki, Tajima, Takeshi, Sakuma, Megumi, Shouji, Michi, Meguro, Hidenori, Saito, Kota, Iwata, Satoshi, Ubukata, Kimiko

“…We compared sequence types (STs) of Mycoplasma pneumoniae isolates from Japan during 2002-2019. ST3 and ST14 dominated during 2002-2016, and ST7 and ST33…”
Get full text

Killing kinetics of minocycline, doxycycline and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae by Morozumi, Miyuki, Okada, Takafumi, Tajima, Takeshi, Ubukata, Kimiko, Iwata, Satoshi

“…Highlights • Macrolide-resistant Mycoplasma pneumoniae (MRMP) infections are increasing worldwide. • Treatment of MRMP poses particular problems in paediatrics…”
Get full text

Hematologic recovery induced by eltrombopag in Japanese patients with aplastic anemia refractory or intolerant to immunosuppressive therapy by Yamazaki, Hirohito, Ohta, Kensuke, Iida, Hiroatsu, Imada, Kazunori, Obara, Naoshi, Tokumine, Yukihiro, Tomiyama, Yoshiaki, Usuki, Kensuke, Imajo, Kenji, Miyamura, Koichi, Sasaki, Osamu, Fanghong, Zhang, Hattori, Toshihiro, Tajima, Takeshi, Matsuda, Akira, Nakao, Shinji

“…Eltrombopag, an oral thrombopoietin-receptor agonist, stimulates hematopoiesis in patients with acquired aplastic anemia (AA) and has higher exposure in…”
Get full text

Eltrombopag in Combination with Rabbit Anti-thymocyte Globulin/Cyclosporine A in Immunosuppressive Therapy-naïve Patients with Aplastic Anemia in Japan by Imada, Kazunori, Obara, Naoshi, Iida, Hiroatsu, Imajo, Kenji, Maeda, Tetsuo, Usuki, Kensuke, Fanghong, Zhang, Hombo, Yosuke, Tajima, Takeshi, Kumagai, Akiko, Matsuda, Akira, Nakao, Shinji

“…Objective In Japan, immunosuppressive therapy (IST) with anti-thymocyte globulin (ATG), and cyclosporine A (CsA) is the standard of care in patients with…”
Get full text

Phase I study of the antiprogrammed cell death‐1 Ab spartalizumab (PDR001) in Japanese patients with advanced malignancies by Minami, Hironobu, Doi, Toshihiko, Toyoda, Masanori, Imamura, Yoshinori, Kiyota, Naomi, Mitsuma, Ayako, Shimokata, Tomoya, Naito, Yoichi, Matsubara, Nobuaki, Tajima, Takeshi, Tokushige, Kota, Ishihara, Kae, Cameron, Scott, Ando, Yuichi

“…Spartalizumab is a humanized IgG4/κ mAb directed against human programmed cell death‐1 (PD‐1). In this phase I study, we investigated safety, pharmacokinetics,…”
Get full text

A Possible Protective Effect of the 'Cam Deformity' on Femoral Neck Fracture: The Relationship between Hip Morphology and the Types of Hip Fracture by Yagura, Takuma, Oe, Kenichi, Paku, Masaaki, Tajima, Takeshi, Nakamura, Masaya, Iida, Hirokazu, Saito, Takanori

“…We retrospectively evaluated the cases of 169 hip fracture patients, their previous fractures, and the contralateral hip joint's morphology. A history of…”
Get full text

Nationwide surveillance of bacterial pathogens isolated from children conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2017: General overview of pathogenic antimicrobial susceptibility by Ishiwada, Naruhiko, Fujimaki, Kazuo, Matsumoto, Tetsuya, Kiyota, Hiroshi, Tateda, Kazuhiro, Sato, Junko, Hanaki, Hideaki, Takayanagi, Reiko, Yamaguchi, Yoshio, Hoshino, Tadashi, Kuroki, Haruo, Iwata, Satoshi, Tajima, Takeshi, Horikoshi, Yuho, Shiro, Hiroyuki, Bamba, Masahiro, Kawamura, Naohisa, Ouchi, Kazunobu, Matsubara, Keita, Okada, Takafumi, Furuno, Kenji, Tsumura, Naoki

“…A nationwide surveillance of the antimicrobial susceptibility of pediatric patients to bacterial pathogens was conducted by Japanese Society of Chemotherapy,…”
Get full text

Pediatric community-acquired pneumonia treated with a three-day course of tebipenem pivoxil by Sakata, Hiroshi, Kuroki, Haruo, Ouchi, Kazunobu, Tajima, Takeshi, Iwata, Satoshi

“…Abstract We evaluated the efficacy and safety of a 3-day treatment regimen of tebipenem pivoxil for pediatric community-acquired pneumonia. Tebipenem pivoxil…”
Get full text

Nationwide survey of the development of drug-resistant pathogens in the pediatric field in 2007 and 2010: drug sensitivity of Streptococcus pneumoniae in Japan (second report) by Tajima, Takeshi, Sato, Yoshitake, Toyonaga, Yoshikiyo, Hanaki, Hideaki, Sunakawa, Keisuke

“…Abstract We previously conducted nationwide surveillance of Streptococcus pneumoniae in 2000–2001 (period 1) and 2004 (period 2) and reported the findings…”
Get full text

Real-time diagnostic analysis of MinION™-based metagenomic sequencing in clinical microbiology evaluation: a case report by Tanaka, Hiromasa, Matsuo, Yoshiyuki, Nakagawa, So, Nishi, Kenichiro, Okamoto, Akihisa, Kai, Shinichi, Iwai, Teppei, Tabata, Yoshiteru, Tajima, Takeshi, Komatsu, Yuji, Satoh, Motohiko, Kryukov, Kirill, Imanishi, Tadashi, Hirota, Kiichi

Get full text

Phase I, multicenter, open‐label, dose‐escalation study of sonidegib in Asian patients with advanced solid tumors by Minami, Hironobu, Ando, Yuichi, Ma, Brigette Buig Yue, Hsiang Lee, Jih‐, Momota, Hiroyuki, Fujiwara, Yutaka, Li, Leung, Fukino, Koichi, Ito, Koji, Tajima, Takeshi, Mori, Asuka, Lin, Chia‐Chi

“…Sonidegib is a selective inhibitor of Smoothened receptor, which is a key regulator of the Hedgehog signaling pathway. The purpose of this study was to…”
Get full text

Phase I study of panobinostat and 5-azacitidine in Japanese patients with myelodysplastic syndrome or chronic myelomonocytic leukemia by Kobayashi, Yukio, Munakata, Wataru, Ogura, Michinori, Uchida, Toshiki, Taniwaki, Masafumi, Kobayashi, Tsutomu, Shimada, Fumika, Yonemura, Masataka, Matsuoka, Fumiko, Tajima, Takeshi, Yakushijin, Kimikazu, Minami, Hironobu

“…The current therapy for high-risk myelodysplastic syndrome (MDS) involves repeated cycles of the DNA demethylating agent 5-azacitidine (5-Aza), but combination…”
Get full text

Emergence of Macrolide-Resistant Mycoplasma pneumoniae with a 23S rRNA Gene Mutation by MOROZUMI, Miyuki, HASEGAWA, Keiko, UBUKATA, Kimiko, KOBAYASHI, Reiko, INOUE, Nagako, IWATA, Satoshi, KUROKI, Haruo, KAWAMURA, Naohisa, NAKAYAMA, Eiichi, TAJIMA, Takeshi, SHIMIZU, Kouichi

“…ERRATUM ( vol. 49 , p. 3100 ) Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg…”
Get full text

Everolimus for advanced pancreatic neuroendocrine tumours: a subgroup analysis evaluating Japanese patients in the RADIANT-3 trial by Ito, Tetsuhide, Okusaka, Takuji, Ikeda, Masafumi, Igarashi, Hisato, Morizane, Chigusa, Nakachi, Kohei, Tajima, Takeshi, Kasuga, Akio, Fujita, Yoshie, Furuse, Junji

“…Everolimus, an inhibitor of the mammalian target of rapamycin, has recently demonstrated efficacy and safety in a Phase III, double-blind, randomized trial…”
Get full text

Simultaneous Detection of Pathogens in Clinical Samples from Patients with Community-Acquired Pneumonia by Real-Time PCR with Pathogen-Specific Molecular Beacon Probes by MOROZUMI, Miyuki, NAKAYAMA, Eiichi, IWATA, Satoshi, AOKI, Yasuko, HASEGAWA, Keiko, KOBAYASHI, Reiko, CHIBA, Naoko, TAJIMA, Takeshi, UBUKATA, Kimiko

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text